Literature DB >> 28446368

Ebola-related stigma in Ghana: Individual and community level determinants.

Eric Y Tenkorang1.   

Abstract

RATIONALE: Although Ebola-related stigmatization continues to undermine efforts to re-integrate survivors, few studies have examined what influences such stigmatizing attitudes.
OBJECTIVE: This paper explores the effects of both individual- and community-level factors on Ebola-related stigma in Ghana.
METHODS: Data were collected from a cross-section of 800 respondents, nested within 40 communities in the Greater Accra Region of Ghana. Multi-level modelling was employed for analysis.
RESULTS: Both individual- and community-level factors were significant determinants of stigma. Respondents who endorsed myths about Ebola were significantly more likely to also endorse Ebola-related stigma. Similarly, those who were worried about a potential outbreak of Ebola in the future, had moderate risk perceptions of contracting Ebola, had primary and secondary education, and were not confident of the quality of health care in the event of an outbreak, were more likely to endorse Ebola-related stigma. Knowledge of Ebola was significant at the community level, but not at the individual level. Communities with more knowledge were less likely to endorse Ebola-related stigma.
CONCLUSIONS: These findings underscore the need to increase the knowledge base while countering myths that undermine preventive behaviours to fight Ebola-related stigma. It is equally important to adopt multi-level interventions that emphasize community-based strategies.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ebola virus disease; Ghana; Knowledge; Multi-level modelling; Myths; Risk perception; Stigma

Mesh:

Year:  2017        PMID: 28446368     DOI: 10.1016/j.socscimed.2017.03.060

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  A post-outbreak assessment of exposure proximity and Ebola virus disease-related stigma among community members in Kono District, Sierra Leone: A cross-sectional study.

Authors:  Michelle C Davidson; Scott Lu; M Bailor Barrie; Adams Freeman; Mohamed Mbayoh; Mohamed Kamara; Alexander C Tsai; Thomas Crea; George W Rutherford; Sheri D Weiser; J Daniel Kelly
Journal:  SSM Ment Health       Date:  2022-01-29

2.  The symbolic violence of 'outbreak': A mixed methods, quasi-experimental impact evaluation of social protection on Ebola survivor wellbeing.

Authors:  Eugene T Richardson; J Daniel Kelly; Osman Sesay; Michael D Drasher; Ishaan K Desai; Raphael Frankfurter; Paul E Farmer; Mohamed Bailor Barrie
Journal:  Soc Sci Med       Date:  2017-11-11       Impact factor: 4.634

3.  COVID-19-related stigma and its sociodemographic correlates: a comparative study.

Authors:  Yuan Yuan; Yan-Jie Zhao; Qing-E Zhang; Ling Zhang; Teris Cheung; Todd Jackson; Guo-Qing Jiang; Yu-Tao Xiang
Journal:  Global Health       Date:  2021-05-07       Impact factor: 4.185

4.  Risk perception during the 2014-2015 Ebola outbreak in Sierra Leone.

Authors:  Maike Winters; Mohamed F Jalloh; Paul Sengeh; Mohammad B Jalloh; Zangin Zeebari; Helena Nordenstedt
Journal:  BMC Public Health       Date:  2020-10-12       Impact factor: 3.295

5.  A systematic review and meta-analysis on the prevalence of stigma in infectious diseases, including COVID-19: a call to action.

Authors:  Kai Yuan; Xiao-Lin Huang; Wei Yan; Yu-Xin Zhang; Yi-Miao Gong; Si-Zhen Su; Yue-Tong Huang; Yi Zhong; Yi-Jie Wang; Ze Yuan; Shan-Shan Tian; Yong-Bo Zheng; Teng-Teng Fan; Ying-Jian Zhang; Shi-Qiu Meng; Yan-Kun Sun; Xiao Lin; Tian-Ming Zhang; Mao-Sheng Ran; Samuel-Yeung-Shan Wong; Nicolas Rüsch; Le Shi; Yan-Ping Bao; Lin Lu
Journal:  Mol Psychiatry       Date:  2021-09-27       Impact factor: 13.437

Review 6.  Precision Global Health - The case of Ebola: a scoping review.

Authors:  Nefti-Eboni Bempong; Rafael Ruiz De Castañeda; Stefanie Schütte; Isabelle Bolon; Olivia Keiser; Gérard Escher; Antoine Flahault
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.